Corrigendum: Correction of the Abstract. Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.

This corrects the article on p. 285 in vol. 63, PMID: 35534217.

Focal therapy for prostate cancer with irreversible electroporation: Oncological and functional results of a single institution study.

Purpose: Focal irreversible electroporation (IRE) for prostate cancer aims to reduce quality of life complications, however outcomes data remains limited. We aimed to evaluate histological in-field clearance of prostate cancer at ≥12 months post-IRE.

Materials And Methods: Retrospective review of prospectively acquired data of consecutive patients treated between August 2018 and August 2021.